Prospective analysis of HLA immunogenicity of cryopreserved valved allografts used in pediatric heart surgery

Circulation

Volumn 94, Issue 5, 1996, Pages 1063-1067

  Shaddy, Robert E ^a,b   Hunter, Dixie D ^a   Osborn, Karen A ^a   Lambert, Linda M ^a   LuAnn Minich, L ^a   Hawkins, John A ^a   McGough, Edwin C ^a   Fuller, Thomas C ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

heart defects, congenital; immune system; pediatrics; valves

Indexed keywords

HLA ANTIGEN CLASS 1;

ADOLESCENT; ALLOTRANSPLANTATION; ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; GRAFT REJECTION; HEART TRANSPLANTATION; HLA TYPING; HUMAN; IMMUNOGENICITY; INFANT; NEWBORN; OPEN HEART SURGERY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0029813488     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.5.1063     Document Type: Article

References (33)

1. Shaddy RE, Tani LY, Sturtevant JE, Lambert LM, McGough EC. Effects of homograft blood type and anatomic type on stenosis, re- gurgitation and calcium in homografts in the pulmonary position. Am J Cardiol. 1992;70:392-393.
2. Hawkins JA, Bailey WW, Dillon T, Schwartz DC. Midterm results with cryopreserved allograft valved conduits from the right ventricle to the pulmonary arteries. J Thorac Cardiovasc Surg. 1992;104:910-916.
3. Bando K, Danielson GK, Schaff HV, Mair DD, Julsrud PR, Puga FJ. Outcome of pulmonary and aortic homografts for right ventricular outflow tract reconstruction. J Thorac Cardiovasc Surg. 1995;109:509-518.
4. Clarke DR, Campbell DN, Hayward AR, Bishop DA. Degeneration of aortic valve allografts in young recipients. J Thorac Cardiovasc Surg. 1993;105:934-943.
5. Salim MA, DiSessa TG, Alpert BS, Arheart KL, Novick WM, Watson DC Jr. The fate of homograft conduits in children with congenital heart disease: an angiographic study. Ann Thorac Surg. 1995;59:67-73.
6. Chan KC, Fyfe DA, McKay CA, Sade RM, Crawford FA. Right ventricular outflow reconstruction with cryopreserved homografts in pediatric patients: intermediate-term follow-up with serial echocardiographic assessment. J Am Coll Cardiol. 1994;24:483-489.
7. Davies H, Lessoff MH, Roberts CI, Ross DN. Homograft replacement of the aortic valve. Lancet. 1965;1:926-929.
8. Davies H, Missen AK, Blandford G, Roberts CI, Lessoff MH, Ross DN. Homograft replacement of the aortic valve. Am J Cardiol. 1968;22:195-217.
9. Lupinetti FM, Christy JP, King DM, el Khatib H, Thompson SA. Immunogenicity, antigenicity, and endothelial viability of aortic valves preserved at 4 degrees C in a nutrient medium. J Card Surg. 1991;6:454-461.
10. Zhao X-M, Green M, Frazer IH, Hogan P, O'Brien MF. Donor-specific immune response after aortic valve allografting in the rat. Ann Thorac Surg. 1994;57:1158-1163.
11. Wagner E, Roy R, Marois Y, Douville Y, Guidoin R. Posttransplant antibodies and fresh venous allograft failure in dogs. Transplantation. 1994;58:537-542.
12. Smith JD, Ogino H, Hunt D, Laylor RM, Rose ML, Yacoub MH. Humoral immune response to human aortic valve homografts. Ann Thorac Surg. 1995;60:S127-S130.
13. Hoekstra F, Knoop C, Jutte N, Wassenar C, Mochtar B, Weimar W. Effect of cryopreservation and HLA-DR matching on the cellular immunogenicity of human cardiac valve allografts. J Heart Lung Transplant. 1993;13:1095-1098.
14. Fischlein T, Schultz A, Haushofer M, Frey R, Uhlig A, Detter C, Reichart B. Immunologic reaction and viability of cryopreserved homografts. Ann Thorac Surg. 1995;60:S122-S126.
15. Motomura N, Imakita M, Yutani C, Takamoto S, Kitoh Y, Tsuji T, Kawashima Y, Wada Y, Oka T. Histologic modification by cryopreservation in rat aortic allografts. Ann Thorac Surg. 1995;60:S168-S171.
16. Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y. Microdroplet testing for HLA-A, -B, -C, and -D antigens. Am J Clin Pathol. 1978;69:103-120.
17. Fuller TC, Phelan D, Gebel HM, Rodey GE. Antigenic specificity of antibody reactivity in the antiglobulin-augmented lymphocytotoxicity test. Transplantation. 1982;34:24-29.
18. Fuller TC. A simple, inexpensive procedure for freezing, storage and recovery of viable human lymphocytes. In: Ray JC, ed. Manual of Tissue Typing Techniques. Washington, DC: DHEW; Publication No. (NIH) 80-545;1979:225-230.
19. Iwaki Y, Lau M, Terasaki PI. Successful transplants across T warm positive crossmatches due to IgM antibodies. Clin Transplant. 1988;2:81-84.
20. Lupinetti FM, Tsai TT, Kneebone JM, Bove EL. Effects of cryopreservation on the presence of endothelial cells on human valve allografts. J Thorac Cardiovasc Surg. 1993;106:912-917.
21. Cochran RP, Kunzelman KS. Cryopreservation does not alter antigenie expression of aortic allografts. J Surg Res. 1989;46:597-599.
22. Tomford WW, Schacher NS, Fuller TC, Henry WB, Mankin HJ. Immunogenicity of frozen osteoarticular allografts. Transplant Proc. 1981;13:888-890.
23. Fuller TC. Laboratory testing in organ transplantation, monitoring HLA alloimmunization: analysis of HLA alloantibodies in the serum of prospective transplant recipients. In: Rodey GE, ed. Clinics of Laboratory Medicine. Philadelphia, Pa: WB Saunders; 1991:551-570.
24. Oldfather J, Mora A, Phelan D, Kehl L, Fuller T, Anderson CB, Sicard G, Etheredge EE, Rodey GE. The occurrence of crossreactive 'public' antibodies in the sera of highly sensitized dialysis patients. Transplant Proc. 1983;14:1212-1215.
25. Lupinetti FM, Cobb S, Kioschos H, Thompson SA, Walters KS, Moore KC. Effect of immunological differences on rat aortic valve allograft calcification. J Card Surg. 1992;7:65-70.
26. Levy RJ, Schoen FJ, Howard SL. Mechanism of calcification of porcine bioprosthetic aortic valve cusps: role of T lymphocytes. Am J Cardiol. 1983;52:629-631.
27. Schmitz-Rixen T, Megerman J, Colvin RB, Williams AM, Abbott WM. Immunosuppressive treatment of aortic allografts. J Vasc Surg. 1988;7:82-92.
28. Yankah AC, Wottge H-U, Muller-Ruchholtz W. Short-course cyclosporin A therapy for definite allograft valve survival immunosuppression in allograft valve operations. Ann Thorac Surg. 1995;60:S146-S150.
29. Pigott JD, Murphy JD, Barber G, Norwood WI. Palliative reconstructive surgery for hypoptastic left heart syndrome. Ann Thorac Surg. 1988;45:122-128.
30. Rose ML. Antibody-mediated rejection following cardiac transplantation. Transplant Rev. 1993;7:140-152.
31. Smith JD, Danskine AJ, Laylor RM, Rose ML, Yacoub MH. The effect of panel reactive antibodies and donor-specific crossmatch on graft survival after heart and heart-lung transplantation. Transplant Immunol. 1993;1:60-65.
32. Lavee J, Kormos RL, Duquesnoy RJ, Zerbe TR, Armitage JM, Vanek M, Hardesty RL, Griffith BP. Influence of panel-reactive antibody and lymphocyte crossmatch on survival after heart transplantation. J Heart Lung Transplant. 1991;101:921-930.
33. Loh E, Bergin JD, Couper GS, Mudge GH. Role of panel-reactive antibody cross-reactivity in predicting survival after orthotopic heart transplantation. J Heart Lung Transplant. 1994;13:194-201.